<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02923193</url>
  </required_header>
  <id_info>
    <org_study_id>CP 60892</org_study_id>
    <nct_id>NCT02923193</nct_id>
  </id_info>
  <brief_title>Shockwave Medical Peripheral Lithoplasty System Study for PAD (Disrupt PAD III)</brief_title>
  <official_title>Randomized Study of the Shockwave Medical Peripheral Lithoplasty® System Used in Combination With DCB Versus Standard Balloon Angioplasty Used in Combination With DCB to Treat Moderate and Severely Calcified Femoropopliteal Arteries</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Shockwave Medical, Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Shockwave Medical, Inc.</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      Shockwave Medical Inc. intends to conduct a prospective, multi-center, single blind,
      randomized (1:1) study of Lithoplasty treatment used in combination with DCB versus standard
      balloon angioplasty used in combination with DCB to treat moderate and severely calcified
      femoropopliteal arteries. Assuming that roughly 15% of the subjects will be
      lost-to-follow-up, a total of up to 400 subjects (200 per treatment arm) will be enrolled in
      the study at up to 60 sites in Europe, the United States and New Zealand.

      In addition to the randomized study, an observational study of subjects who do not meet the
      inclusion/exclusion criteria for the randomized study will be conducted. The objective of the
      observational study is to assess the real-world acute performance of the Shockwave Medical
      Peripheral Lithoplasty System in the treatment of calcified, stenotic, peripheral arteries.

      The observational study is a prospective, multi-center, single arm observational study for
      subjects who do not meet the inclusion/exclusion criteria of the randomized study.

      A maximum of 1000 subjects at the same 60 sites will be enrolled in the observational study.
      Once enrollment in the randomized portion of the study is complete, subjects may continue to
      be enrolled in the observational study provided they meet OS eligibility criteria.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Shockwave Medical Inc. intends to conduct a prospective, multi-center, single blind,
      randomized (1:1) study of Lithoplasty treatment used in combination with DCB versus standard
      balloon angioplasty used in combination with DCB to treat moderate and severely calcified
      femoropopliteal arteries. The Shockwave Medical Peripheral Lithoplasty System is indicated
      for lithotripsy-enhanced, low-pressure balloon dilatation of calcified, stenotic peripheral
      arteries in patients who are candidates for percutaneous therapy. Up to 400 subjects at 60
      sites in Europe, the United States and New Zealand.

      Subjects will be followed through discharge, 30 days, and 6, 12 and 24 months. DUS
      assessments will be completed at 12 and 24 months. Procedural success is defined as residual
      stenosis ≤30% without flow-limiting dissection (≥ grade D) prior to DCB or stenting by
      angiographic core lab.

      Subjects who do not meet the randomized study inclusion and exclusion criteria, but meet the
      inclusion and exclusion criteria for the observational study may be enrolled in the
      observational study. The objective of the observational study is to assess the real-world
      acute performance of the Shockwave Medical Lithoplasty System in the treatment of calcified,
      stenotic, peripheral arteries.The observational study is a prospective, multi-center, single
      arm observational study for subjects who do not meet the inclusion/exclusion criteria of the
      randomized study. A maximum of 1000 subjects at the same 60 sites will be enrolled in the
      observational study. Procedural success is defined as residual stenosis ≤30% without
      flow-limiting dissection (≥ grade D) prior to DCB or stenting by angiographic core lab.
      Enrollment in the observational study is anticipated to last approximately 22 months.
      Subjects in the observational study will be followed through hospital discharge. Once
      enrollment in the randomized portion of the study is complete, subjects may continue to be
      enrolled in the observational study provided they meet OS eligibility criteria.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">February 22, 2017</start_date>
  <completion_date type="Anticipated">December 2021</completion_date>
  <primary_completion_date type="Anticipated">December 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Procedural success is defined as residual stenosis ≤30% without flow-limiting dissection (≥ grade D) prior to DCB or stenting by angiographic core lab.</measure>
    <time_frame>Peri-Procedural</time_frame>
    <description>Procedural success is defined as residual stenosis ≤30% without flow-limiting dissection (≥ grade D) prior to DCB or stenting by angiographic core lab.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Primary patency defined as freedom from clinically-driven target lesion revascularization (TLR) and freedom from restenosis determined by duplex ultrasound or angiogram greater than or equal to 50% stenosis.</measure>
    <time_frame>Peri-Procedural</time_frame>
    <description>Acute PTA failure requiring a stent at any time during the index procedure will be counted as a loss of primary patency.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Composite of new-onset Major Adverse Events (MAEs)</measure>
    <time_frame>Within 30 days, 6, 12 and 24 months post procedure</time_frame>
    <description>Need for emergency surgical revascularization of target limb
Unplanned target limb major amputation (above the ankle)
Symptomatic thrombus or distal emboli that require surgical, mechanical or pharmacologic means to improve flow and extend hospitalization
Perforations that require an intervention, including bail-out stenting</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Primary patency</measure>
    <time_frame>30 days, 6, 12 and 24 months</time_frame>
    <description>Defined as freedom from clinically-driven target lesion revascularization (TLR)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Clinical Success ABI</measure>
    <time_frame>30 days, 6, 12 and 24 months</time_frame>
    <description>Defined as ankle-brachial index ABI reported as change from baseline</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Clinical Success Rutherford Category</measure>
    <time_frame>30 days, 6, 12 and 24 months</time_frame>
    <description>Defined as Rutherford Category reported as change from baseline</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Clinical Success Quality of Life</measure>
    <time_frame>30 days, 6, 12 and 24 months</time_frame>
    <description>Defined by Quality of Life assessed by EQ5D questionnaire reported as change from baseline</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">400</enrollment>
  <condition>Peripheral Arterial Disease</condition>
  <arm_group>
    <arm_group_label>Lithoplasty System followed by DCB</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Shockwave Lithoplasty® Peripheral Lithoplasty System is a lithotripsy-enhanced, low-pressure balloon dilatation of calcified, stenotic peripheral arteries in patients who are candidates for percutaneous therapy. lithoplasty</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Medtronic IN.PACT (DCB)</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Medronic IN.PACT Drug Coated Balloon (DBS) is indicated for percutaneous transluminal angioplasty (PTA) in patients with obstructive disease of peripheral arteries, including patients with in-stent restenosis (ISR) and arteriovenous (AV) access to help maintain hemodialysis access in patients with end-stage renal disease.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Shockwave Lithoplasty® Peripheral Lithoplasty System</intervention_name>
    <description>The Shockwave Lithoplasty® System is a proprietary lithotripsy-enhanced balloon catheter that is designed to be delivered through the peripheral arterial system of the lower extremities to the site of calcified stenosis. Activating the lithotripsy within the device will generate pulsatile mechanical energy within the target treatment site, disrupt calcium within the lesion and allow subsequent dilation of a peripheral artery stenosis using low balloon pressure. The system consists of a balloon catheter with multiple integrated lithotripsy electrodes, and a generator.</description>
    <arm_group_label>Lithoplasty System followed by DCB</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Medtronic IN.PACT (DCB)</intervention_name>
    <description>The IN.PACT Admiral DCB is an over-the-wire (OTW) balloon catheter with a drug-coated balloon at the distal tip. The drug component, referred to as the FreePac™ drug coating, consists of the drug paclitaxel and the excipient urea. The device component physically dilates the vessel lumen by PTA, and the drug is intended to reduce the proliferative response that is associated with restenosis.</description>
    <arm_group_label>Lithoplasty System followed by DCB</arm_group_label>
    <arm_group_label>Medtronic IN.PACT (DCB)</arm_group_label>
    <other_name>drug coated balloon</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Randomized Study Arm Eligibility Criteria

        General Inclusion Criteria

          1. Subject is able and willing to comply with all assessments in the study.

          2. Subject or subject's legal representative have been informed of the nature of the
             study, agrees to participate and has signed the approved consent form.

          3. Age of subject is greater than or equal to 18.

          4. Rutherford Clinical Category 2, 3, or 4 of the target limb.

          5. Estimated life expectancy &gt;1 year.

          6. Subject is a suitable candidate for angiography and endovascular intervention in the
             opinion of the investigator or per hospital guideline.

          7. Subject is intended to undergo treatment with Lithoplasty followed by DCB, or DCB with
             standard balloon pre-dilatation.

             Angiographic Inclusion Criteria

          8. Target lesion that is located in a native, de novo superficial femoral artery (SFA) or
             popliteal artery (popliteal artery extends to and ends proximal to the ostium of the
             anterior tibial artery).

          9. Target lesion reference vessel diameter is between 4.0mm and 7.0mm by visual estimate.

         10. Target lesion is ≥70% stenosis by investigator via visual estimate.

         11. Target lesion length is ≤180mm for lesions 70-99% stenosed. Target lesion can be all
             or part of the 180mm treated zone.

         12. Chronic total occlusion, lesion length is ≤100mm of the total ≤180 mm target lesion.

         13. Subject has at least one patent tibial vessel on the target leg with runoff to the
             foot, defined as no stenosis &gt;50%.

         14. Calcification is at least moderate defined as presence of fluoroscopic evidence of
             calcification: 1) on parallel sides of the vessel and 2) extending &gt; 50% the length of
             the lesion if lesion is ≥50mm in length; or extending for minimum of 20mm if lesion is
             &lt;50mm in length.

        General Exclusion Criteria

          1. Rutherford Clinical Category 0, 1, 5 and 6.

          2. Subject has active infection requiring antibiotic therapy.

          3. Planned target limb major amputation (above the ankle).

          4. History of prior endovascular or surgical procedure on the index limb within the past
             30 days or planned within 30 days of the index procedure.

          5. Subject has a known coagulopathy or has bleeding diatheses, thrombocytopenia with
             platelet count less than 100,000/microliter.

          6. Subject in whom antiplatelet or anticoagulant therapy is contraindicated.

          7. Subject has known allergy to contrast agents or medications used to perform
             endovascular intervention that cannot be adequately pre-treated.

          8. Subject has known allergy to urethane, nylon, or silicone.

          9. Myocardial infarction within 60 days prior to enrollment.

         10. History of stroke within 60 days prior to enrollment.

         11. History of thrombolytic therapy within two weeks of enrollment.

         12. Subject has acute or chronic renal disease defined as serum creatinine of &gt;2.5 mg/dL
             or &gt;220 umol/L, or on dialysis.

         13. Subject is pregnant or nursing.

         14. Subject is participating in another research study involving an investigational agent
             (pharmaceutical, biologic, or medical device) that has not reached the primary
             endpoint.

         15. Subject has other medical, social or psychological problems that, in the opinion of
             the investigator, preclude them from receiving this treatment, and the procedures and
             evaluations pre- and post-treatment.

         16. The use of specialty balloons, re-entry or atherectomy devices.

             Angiographic Exclusion Criteria

         17. In-stent restenosis within 10mm of the target zone.

         18. Lesions within 10mm of the ostium of the SFA or within 10mm of the ostium of the
             anterior tibial artery.

         19. Evidence of aneurysm or thrombus in target vessel.

         20. No calcium or mild calcium in the target lesion.

         21. Target lesion within native or synthetic vessel grafts.

         22. Subject has significant stenosis (&gt;50% stenosis) or occlusion of inflow tract before
             target treatment zone (e.g. iliac or common femoral) not successfully treated.

         23. Subject requires treatment of a peripheral lesion on the ipsilateral limb distal to
             target site at the time of the index procedure.

         24. Failure to successfully cross the guidewire across the target lesion; successful
             crossing defined as tip of the guidewire distal to the target lesion in the absence of
             flow limiting dissections or perforations.

        Subjects who do not meet the inclusion/exclusion criteria for the randomized study may
        satisfy the eligibility criteria for the observational study.

        Observational Study Eligibility Criteria

        Inclusion Criteria

          1. Subjects intended to be treated with the Shockwave Medical Peripheral Lithoplasty®
             System for de-novo or restenotic lesions of the femoral, ilio-femoral, popliteal, and
             infra-popliteal arteries.

          2. Subjects presenting with claudication or CLI by Rutherford Clinical Category 2,3,4,5,
             or 6 of the target limb.

          3. Age of subject is &gt; 18.

          4. Subject or subject's legal representative have been informed of the nature of the
             study, agrees to participate, and has signed the approved study consent form.

          5. Calcification is at least moderate, defined as presence of fluoroscopic evidence of
             calcification: 1) on parallel sides of the vessel and 2) extending &gt; 50% the length of
             the lesion if lesion is ≥50mm in length; or extending for minimum of 20mm if lesion is
             &lt;50mm in length.

        Exclusion Criteria

          1. Subjects with any medical condition that would make him/her an inappropriate candidate
             for treatment with Shockwave Medical Peripheral Lithoplasty® System as per
             Instructions for Use (IFU) or investigator's opinion.

          2. Subject is already enrolled in other investigational (interventional) studies that
             would interfere with study endpoints.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Gunnar Tepe, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>RoMed Klinikum Rosenheim</affiliation>
  </overall_official>
  <overall_official>
    <last_name>William A Gray, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Main Line Health</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Alexis Brash</last_name>
    <phone>1-510-624-9093</phone>
    <email>abrash@shockwavemedical.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Abrazo Arizona Heart Hospital</name>
      <address>
        <city>Phoenix</city>
        <state>Arizona</state>
        <zip>85016</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Withdrawn</status>
  </location>
  <location>
    <facility>
      <name>Arkansas Heart Hospital</name>
      <address>
        <city>Little Rock</city>
        <state>Arkansas</state>
        <zip>72211</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mary Catherine Faulkner</last_name>
      <phone>501-748-8421</phone>
      <email>MaryCatherine.Faulkner@arheart.com</email>
    </contact>
    <investigator>
      <last_name>Ian Cawich, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Andre Paixao</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Vijay Raja</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Stanford Hospital</name>
      <address>
        <city>Palo Alto</city>
        <state>California</state>
        <zip>94304</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Tiffany Flores</last_name>
      <phone>650-725-8718</phone>
      <email>Tflores2@Stanford.edu</email>
    </contact>
    <investigator>
      <last_name>Claire A Watkins, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Venita Chandra</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Ron Dalman</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>E. John Harris</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Jason Lee</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Rocky Mountain Regional VA Medical Center</name>
      <address>
        <city>Aurora</city>
        <state>Colorado</state>
        <zip>80045</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Michele Corbet</last_name>
      <phone>720-723-6418</phone>
      <email>michele.corbet@ucdenver.edu</email>
    </contact>
    <investigator>
      <last_name>Ehrin Armstrong, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>UCHealth Northern Colorado</name>
      <address>
        <city>Loveland</city>
        <state>Colorado</state>
        <zip>80538</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Scott Kaczkowski</last_name>
      <phone>970-624-1685</phone>
      <email>scott.kaczkowski@uchealth.org</email>
    </contact>
    <investigator>
      <last_name>William Miller, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Philip Dattilo</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Yale New Haven Hospital</name>
      <address>
        <city>New Haven</city>
        <state>Connecticut</state>
        <zip>06510</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Dawn Shaddinger, RN</last_name>
      <phone>203-737-3570</phone>
      <email>dawn.shaddinger@yale.edu</email>
    </contact>
    <investigator>
      <last_name>Carlos Mena, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Robert Attaran</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Christopher Regan</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Glen Henry</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Costin Ionescu</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>MedStar Cardiovascular Research Network @ Medstar Washington Hospital Center</name>
      <address>
        <city>Washington</city>
        <state>District of Columbia</state>
        <zip>20010</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Suman Singh</last_name>
      <phone>202-877-8475</phone>
      <email>Suman.Singh@medstar.net</email>
    </contact>
    <investigator>
      <last_name>Edward Woo, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Steven Abramowitz</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Nelson Bernardo</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Tallahassee Research Institute, Inc.</name>
      <address>
        <city>Tallahassee</city>
        <state>Florida</state>
        <zip>32308</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Rebecca Plasay</last_name>
      <phone>850-431-5024</phone>
      <email>rebecca.plasay@tmh.org</email>
    </contact>
    <investigator>
      <last_name>William Dixon, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>John Katopodis</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Thomas Noel</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Piedmont Heart Institute</name>
      <address>
        <city>Atlanta</city>
        <state>Georgia</state>
        <zip>30309</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Festus Oyedokun</last_name>
      <phone>404-605-2327</phone>
      <email>Festus.oyedokun@piedmont.org</email>
    </contact>
    <investigator>
      <last_name>Andrew Klein, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>David Kandzari</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Prashant Kaul</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Charles Ross</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Andrew Unzeitig</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Northeast Georgia Medical Center</name>
      <address>
        <city>Gainesville</city>
        <state>Georgia</state>
        <zip>30501</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Donna Patrick</last_name>
      <phone>678-989-5001</phone>
      <email>donna.patrick@nghs.com</email>
    </contact>
    <investigator>
      <last_name>Ankit Patel</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>James Reeves</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Alexian Brothers Medical Center</name>
      <address>
        <city>Elk Grove Village</city>
        <state>Illinois</state>
        <zip>60007</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>April Levesque</last_name>
      <email>april.levesque@amitahealth.org</email>
    </contact>
    <investigator>
      <last_name>Jack Chamberlin, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Atif Baqai</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Firas Barrow</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Paul Grunenwald</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Saba Khan</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Andrei Pop</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Bharat Samy</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Advocate Health and Hospitals Corporation</name>
      <address>
        <city>Naperville</city>
        <state>Illinois</state>
        <zip>60540</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kim Paprockas</last_name>
      <email>kimberly.paprockas@advocatehealth.com</email>
    </contact>
    <investigator>
      <last_name>Mark Goodwin, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Pratik Parikh</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Mahesh Raju</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Anand Ramanathan</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Morgan Johnson</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Prairie Education &amp; Research Cooperative</name>
      <address>
        <city>Springfield</city>
        <state>Illinois</state>
        <zip>62769</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kelse Mather</last_name>
      <phone>217-492-9100</phone>
      <phone_ext>29122</phone_ext>
      <email>kmather@prairieresearch.com</email>
    </contact>
    <investigator>
      <last_name>Nilesh J. Goswami, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Jeffrey Goldstein</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Gabor Matos</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Midwest Cardiovascular Research Foundation</name>
      <address>
        <city>Davenport</city>
        <state>Iowa</state>
        <zip>52803</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>John Shammas</last_name>
      <phone>563-324-2828</phone>
      <phone_ext>108</phone_ext>
      <email>shammasw@mcrfmd.com</email>
    </contact>
    <investigator>
      <last_name>Nicholas Shammas, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Shawna Duske</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Steward St. Elizabeth's Medical Center</name>
      <address>
        <city>Brighton</city>
        <state>Maine</state>
        <zip>02135</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Meheret Abebe</last_name>
      <phone>617-789-3041</phone>
      <email>Meheret.Abebe@steward.org</email>
    </contact>
    <investigator>
      <last_name>Lawrence Garcia, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Ascension / St. John Hospital and Medical Center</name>
      <address>
        <city>Detroit</city>
        <state>Michigan</state>
        <zip>48236</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Withdrawn</status>
  </location>
  <location>
    <facility>
      <name>St. Joseph Mercy Oakland</name>
      <address>
        <city>Pontiac</city>
        <state>Michigan</state>
        <zip>48431</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lynn Boomer</last_name>
      <phone>248-858-3756</phone>
      <email>lynn.boomer@stjoeshealth.org</email>
    </contact>
    <investigator>
      <last_name>Kirit Patel, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Abdul Halabi</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Michele de Gregorio</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Ascension / St. John Providence</name>
      <address>
        <city>Southfield</city>
        <state>Michigan</state>
        <zip>48075</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jean Kelly</last_name>
      <phone>248-849-3369</phone>
      <email>jean.kelly@ascension.org</email>
    </contact>
    <investigator>
      <last_name>Patrick Alexander, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>North Mississippi Medical Center</name>
      <address>
        <city>Tupelo</city>
        <state>Mississippi</state>
        <zip>38801</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kelly Hollis</last_name>
      <phone>662-620-6835</phone>
      <email>KDHollis@nmhs.net</email>
    </contact>
    <investigator>
      <last_name>Barry Bertolet, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Joseph Stinson</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Saint Luke's Cardiovascular Consultants</name>
      <address>
        <city>Kansas City</city>
        <state>Missouri</state>
        <zip>64111</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jamie Hall</last_name>
      <phone>816-932-8632</phone>
      <email>jhall@saint-lukes.org</email>
    </contact>
    <investigator>
      <last_name>Steven Laster, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Matthew Bunte</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Jason Lindsey</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>David Safley</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Adam Salisbury</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>St. Luke's East Hospital</name>
      <address>
        <city>Lee's Summit</city>
        <state>Missouri</state>
        <zip>64086</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jackie Smith</last_name>
      <phone>816-932-1627</phone>
      <email>jnsmith@saint-lukes.org</email>
    </contact>
    <investigator>
      <last_name>Steven Laster, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Matthew Bunte</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Adam Salisbury</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>David Safley</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Jason Lindsey</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Saint Louis University</name>
      <address>
        <city>Saint Louis</city>
        <state>Missouri</state>
        <zip>63110</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Withdrawn</status>
  </location>
  <location>
    <facility>
      <name>Deborah Heart and Lung Center</name>
      <address>
        <city>Browns Mills</city>
        <state>New Jersey</state>
        <zip>08015</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lisa Romano</last_name>
      <phone>609-893-1200</phone>
      <phone_ext>5028</phone_ext>
      <email>romanol@deborah.org</email>
    </contact>
    <investigator>
      <last_name>Vince Varghese, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Richard Kovach</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Kintur Sanghvi</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>New Mexico Heart Institute</name>
      <address>
        <city>Albuquerque</city>
        <state>New Mexico</state>
        <zip>87102</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jennifer Cordova</last_name>
      <email>jenniferrom@nmhi.com</email>
    </contact>
    <investigator>
      <last_name>Steve Henao, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Trent Proffitt</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Richard Wilkerson</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Mount Sinai West</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10019</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Emily Pesek</last_name>
      <phone>212-523-5915</phone>
      <email>emily.pesek@mountsinai.org</email>
    </contact>
    <investigator>
      <last_name>James McKinsey, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Icahn School of Medicine at Mount Sinai</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10029</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Miguel Vasquez</last_name>
      <email>miguel.vasquez@mountsinai.org</email>
    </contact>
    <investigator>
      <last_name>Prakash Krishnan, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Karthik Gujja</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Vishal Kapur</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Columbia University Medical Center/New York Presbyterian Hospital</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10032</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Luz Jaquez</last_name>
      <phone>212-342-3489</phone>
      <email>lj2282@cumc.columbia.edu</email>
    </contact>
    <investigator>
      <last_name>Sahil Parikh, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Phil Green</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Ajay Kirtane</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Anthony Pucillo</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Nicholas Morrissey</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Virendra Patel</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Danielle Bajakian</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>NC Heart &amp; Vascular Research</name>
      <address>
        <city>Raleigh</city>
        <state>North Carolina</state>
        <zip>27607</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Shayna Wolery</last_name>
      <phone>919-784-3413</phone>
      <email>Shayna.Wolery@unchealth.unc.edu.brandner@unchealth.unc.edu</email>
    </contact>
    <investigator>
      <last_name>George Adams, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Dorian DeFreitas</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Jason Kim</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Martyn Knowles</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Robert Mendes</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Liliana Nanez</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Ravish Sachar</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>James Zidar</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Joel Schneider</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Mohit Pasi</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>WakeMed Health &amp; Hospitals</name>
      <address>
        <city>Raleigh</city>
        <state>North Carolina</state>
        <zip>27610</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Annsley Winders</last_name>
      <phone>919-350-1047</phone>
      <phone_ext>425</phone_ext>
      <email>awinders@wakemed.org</email>
    </contact>
    <investigator>
      <last_name>Siddhartha Rao, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Brian Go</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Pratik Desai</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Ohio Health Research Institute</name>
      <address>
        <city>Columbus</city>
        <state>Ohio</state>
        <zip>43214</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Johnna Booker</last_name>
      <phone>614-566-1272</phone>
      <email>Johnna.Booker@ohiohealth.com</email>
    </contact>
    <investigator>
      <last_name>John A Phillips, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Gary Ansel, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Charles Botti</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Mitchell Silver</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Michael Jolly</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>St. John Clinic</name>
      <address>
        <city>Bartlesville</city>
        <state>Oklahoma</state>
        <zip>74006</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mary Harris, RN</last_name>
      <phone>918-322-3616</phone>
      <email>Mary.Harris5@ascension.org</email>
    </contact>
    <investigator>
      <last_name>Anderson Mehrle, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Mollie Bechtelheimer</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Andrew Kurklinsky</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Providence Portland Medical Center</name>
      <address>
        <city>Portland</city>
        <state>Oregon</state>
        <zip>97213</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Gretchen Sminkey</last_name>
      <email>gretchen.sminkey@providence.org</email>
    </contact>
    <investigator>
      <last_name>Ethan Korngold, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Charles Cannan</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Brandon Jones</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Aditi Madabhushi</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Alejandro Perez</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Vincent Santo</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Brant Ullery</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Jason Wollmuth</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Providence Heart &amp; Vascular Institute</name>
      <address>
        <city>Portland</city>
        <state>Oregon</state>
        <zip>97225</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Gretchen Sminkey</last_name>
      <email>gretchen.sminkey@providence.org</email>
    </contact>
    <investigator>
      <last_name>Ethan Korngold, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Charles Cannan</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Brandon Jones</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Aditi Madabhushi</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Alejandro Perez</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Vincent Santo</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Brant Ullery</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Jason Wollmuth</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Bryn Mawr Hospital</name>
      <address>
        <city>Bryn Mawr</city>
        <state>Pennsylvania</state>
        <zip>19010</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ann Marie Chikowski, RN</last_name>
      <phone>484-476-8579</phone>
      <email>ChikowskiA@mlhs.org</email>
    </contact>
    <investigator>
      <last_name>Sarang Mangalmurti</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Antonis Pratsos</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>William Gray</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Francis Day</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>PinnacleHealth Harrisburg Hospital</name>
      <address>
        <city>Harrisburg</city>
        <state>Pennsylvania</state>
        <zip>17101</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Seth Arthur</last_name>
      <phone>717-920-4400</phone>
      <phone_ext>4476</phone_ext>
      <email>sarthur@pinnaclehealth.org</email>
    </contact>
    <investigator>
      <last_name>William Bachinsky, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>David Chang</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Cleon Hubbard</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>David Loran</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Anay Pradhan</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>PENN Presbyterian Medical Center</name>
      <address>
        <city>Philadelphia</city>
        <state>Pennsylvania</state>
        <zip>19104</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Elizabeth Medenilla</last_name>
      <phone>215-662-9084</phone>
      <email>Elizabeth.Medenilla@uphs.upenn.edu</email>
    </contact>
    <investigator>
      <last_name>Arthur Topoulos, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Robert Fenning</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Alan Moak</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Einstein Medical Center Philadelphia</name>
      <address>
        <city>Philadelphia</city>
        <state>Pennsylvania</state>
        <zip>19141</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kinnari Murthy</last_name>
      <phone>215-456-1959</phone>
      <email>murthyK@einstein.edu</email>
    </contact>
    <investigator>
      <last_name>Sean Janzer, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Jon George</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Lankenau Institute for Medical Research</name>
      <address>
        <city>Wynnewood</city>
        <state>Pennsylvania</state>
        <zip>19096</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ann Marie Chikowski</last_name>
      <phone>484-476-8579</phone>
      <email>ChikowskiA@mlhs.org</email>
    </contact>
    <investigator>
      <last_name>Sarang Mangalmurti, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Antonis Pratsos</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Willaim Gray</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Francis Day</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>The Miriam Hospital</name>
      <address>
        <city>Providence</city>
        <state>Rhode Island</state>
        <zip>02906</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lina Felix, RN</last_name>
      <phone>401-793-4105</phone>
      <email>lfelix@lifespan.org</email>
    </contact>
    <investigator>
      <last_name>Peter Soukas, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Omar Hyder</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Shafiq Mamdani</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Vascular Associates</name>
      <address>
        <city>Sioux Falls</city>
        <state>South Dakota</state>
        <zip>57105</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Withdrawn</status>
  </location>
  <location>
    <facility>
      <name>Wellmont CVA Heart Institute</name>
      <address>
        <city>Kingsport</city>
        <state>Tennessee</state>
        <zip>37660</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Gina Dugger</last_name>
      <phone>423-390-5406</phone>
      <email>gina.dugger2@balladhealth.org</email>
    </contact>
    <investigator>
      <last_name>Christopher Metzger, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Mark Aziz</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Tennova Healthcare - Turkey Creek Medical Center</name>
      <address>
        <city>Knoxville</city>
        <state>Tennessee</state>
        <zip>37934</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Constance Bales, RN</last_name>
      <phone>865-218-7540</phone>
      <email>constance.bales@tennova.com</email>
    </contact>
    <investigator>
      <last_name>Malcolm Foster III, MD, FACC</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Mukesh Sharma, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Ravi Mehta</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Stephen Miller</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Erica Elliot</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Baptist Medical Center</name>
      <address>
        <city>Memphis</city>
        <state>Tennessee</state>
        <zip>38120</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Amber Turner</last_name>
      <phone>901-747-1268</phone>
      <email>amber@cvsclinic.com</email>
    </contact>
    <investigator>
      <last_name>Edward Garrett, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>St. David's Heart and Vascular dba Austin Heart</name>
      <address>
        <city>Austin</city>
        <state>Texas</state>
        <zip>78757</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Maurene Cantu</last_name>
      <email>maurene.cantu@stdavids.com</email>
    </contact>
    <investigator>
      <last_name>Roger Gammon, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Mark Picone</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Matt Selmon</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Frank Zidar</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Barbara Solnek</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Joanna Brand</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Joan Hughart</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Nancy Rose</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Thomas Carlson</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Baylor College of Medicine</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>77030</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mohammad Shahbazi</last_name>
      <email>mohammad.shahbazi@bcm.edu</email>
    </contact>
    <investigator>
      <last_name>Miguel Montero, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Joseph Mills</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Jayer Chung</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Neil Strickman</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Zvonimir Krajcer</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Charleston Area Medical Center</name>
      <address>
        <city>Charleston</city>
        <state>West Virginia</state>
        <zip>25304</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Briana Knapp</last_name>
      <phone>304-388-9956</phone>
      <email>Briana.knapp@camc.org</email>
    </contact>
    <investigator>
      <last_name>Aravinda Nanjundappa, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Albeir Mousa</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Medizinische Universitaet Graz</name>
      <address>
        <city>Graz</city>
        <zip>8036</zip>
        <country>Austria</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Gabi Platzer</last_name>
      <phone>43 316 385 86112</phone>
      <email>Gabriele.Platzer@klinikum-graz.at</email>
    </contact>
    <investigator>
      <last_name>Marianne Brodmann, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Peter Rief</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Franz Hafner</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Gefäßsambulanz</name>
      <address>
        <city>Vienna</city>
        <zip>1140</zip>
        <country>Austria</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Silvia Schmid</last_name>
      <phone>+43 0699 10707712</phone>
      <email>schmid@viennavascular.at</email>
    </contact>
    <investigator>
      <last_name>Martin Werner, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Karolinen-Hospital</name>
      <address>
        <city>Arnsberg</city>
        <zip>59759</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Simone Mueller</last_name>
      <phone>+49 (0) 2932 952-244820</phone>
      <email>si.mueller@studynurse-si.de</email>
    </contact>
    <investigator>
      <last_name>Michael Lichtenberg, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Stahlhoff</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Universitäts-Herzzentrum Freiburg &amp; Bad Krozingen</name>
      <address>
        <city>Bad Krozingen</city>
        <zip>79189</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jochen Strübin</last_name>
      <phone>+49 7633 402-4984</phone>
      <email>jochen.struebin@universitaets-herzzentrum.de</email>
    </contact>
    <investigator>
      <last_name>Thomas Zeller, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Elias Noory</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Krista Schöllhorn</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Peter Flügel</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Ellen Gebauer</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Ulrich Beschorner</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Borries Jacques</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Alea Nazary</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Mark Kerber</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Sankt Gertrauden-Krankenhaus</name>
      <address>
        <city>Berlin</city>
        <zip>10713</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Heike Bütow</last_name>
      <phone>+49 (0)30 8272 11043</phone>
      <email>Heike.Buetow@sankt-gertrauden.de</email>
    </contact>
    <investigator>
      <last_name>Ralf Langhoff, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Andrea Behne</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Mehmet Boral</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>International Center for Cardiovascular Interventions (ICCI)</name>
      <address>
        <city>Bonn</city>
        <zip>53105</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Tanja Streuber</last_name>
      <email>tanja.streuber@ukb.uni-bonn.de</email>
    </contact>
    <investigator>
      <last_name>Nikos Werner, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Leiter Sektion Angiologie</name>
      <address>
        <city>Bonn</city>
        <zip>53127</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Tanja Streuber</last_name>
      <email>tanja.streuber@ukb.uni-bonn.de</email>
    </contact>
    <investigator>
      <last_name>Nadjib Schahab, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Nikos Werner, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Medizinische Klinik II</name>
      <address>
        <city>Bruchsal</city>
        <zip>76646</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Manuela Scherer-Stolz</last_name>
      <phone>49 7251 708 58506</phone>
      <email>manuela.scherer-stolz@kliniken-lk.de</email>
    </contact>
    <investigator>
      <last_name>Martin Andrassy, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Klinik für Gefäßmedizin</name>
      <address>
        <city>Hamburg</city>
        <zip>21075</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lisa Strauß</last_name>
      <phone>+49 (0) 40 - 1818 86 56 66</phone>
      <email>l.strauss@asklepios.com</email>
    </contact>
    <investigator>
      <last_name>Hans Krankenberg, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Nickling</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Universitätsklinikum Leipzig AoR Leipzig</name>
      <address>
        <city>Leipzig</city>
        <zip>04103</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Janine Brunotte</last_name>
      <phone>+49 341 97 18776</phone>
      <email>janine.brunotte@medizin.uni-leipzig.de</email>
    </contact>
    <investigator>
      <last_name>Dierk Scheinert, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Franka Borger, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Andrej Schmidt</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Axel Fischer</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Yvonne Bausback</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Renaldo Myrselai</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Corneliu Popescu</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Manuela Matschuck</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Katholisches Klinikum Mainz</name>
      <address>
        <city>Mainz</city>
        <zip>55131</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Bärbel Kaesberger</last_name>
      <phone>0049 - ( 0 ) 6131 575 83 1526</phone>
      <email>b-kaesberger@kkmainz.de</email>
    </contact>
    <investigator>
      <last_name>John O Balzer, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Anna Koll</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>St. Franziskus Hospital</name>
      <address>
        <city>Munster</city>
        <zip>48145</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Bärbel Berekoven</last_name>
      <phone>+49 (0) 251 935 3979</phone>
      <email>baerbel.berekoven@sfh-muenster.de</email>
    </contact>
    <investigator>
      <last_name>Arne Schwindt, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Donas Konstantinos</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Evangelisches Krankenhaus Mühlheim an der Ruhr</name>
      <address>
        <city>Mülheim</city>
        <zip>45468</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Gundula Schulz</last_name>
      <email>Gundula.schulz@evkmh.de</email>
    </contact>
    <investigator>
      <last_name>Claus Nolte-Ernsting, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Papaioannou</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Mecklenbeck</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Bekker</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Stehr</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Schulz</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Exler</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>RoMed Klinikum Rosenheim</name>
      <address>
        <city>Rosenheim</city>
        <zip>83022</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Erika Rinser</last_name>
      <phone>+49 (0) 8031 365 35 62</phone>
      <phone_ext>35 53</phone_ext>
      <email>erika.rinser@ro-med.de</email>
    </contact>
    <investigator>
      <last_name>Gunnar Tepe, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Peter Pfaffinger</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Auckland City Hospital</name>
      <address>
        <city>Auckland</city>
        <zip>1023</zip>
        <country>New Zealand</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Helen Knight</last_name>
      <phone>(09) 3074949</phone>
      <phone_ext>24756</phone_ext>
      <email>Hknight@adhb.govt.nz</email>
    </contact>
    <investigator>
      <last_name>Andrew Holden, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Andrew Hill</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Arshad Sheriff</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Austria</country>
    <country>Germany</country>
    <country>New Zealand</country>
    <country>United States</country>
  </location_countries>
  <verification_date>August 2019</verification_date>
  <study_first_submitted>September 28, 2016</study_first_submitted>
  <study_first_submitted_qc>September 30, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 4, 2016</study_first_posted>
  <last_update_submitted>August 26, 2019</last_update_submitted>
  <last_update_submitted_qc>August 26, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">August 28, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Peripheral Arterial Disease</mesh_term>
    <mesh_term>Peripheral Vascular Diseases</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

